AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Fpgli M 0.5 Tablet PR

Prescription Icon
Prescription Required

Marketer

Azkka Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Fpgli M 0.5 Tablet PR

Glycema Duo 0.5mg tablets are classified as antidiabetic medications, combining two agents to manage type 2 diabetes in adults. This formulation assists in regulating blood glucose. Glycema Duo 0.5mg should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continued use is crucial, even with well-managed blood sugar; discontinuation without medical guidance elevates the risk of hyperglycemia, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as directed by your doctor. Lifestyle choices are vital in diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily accessible glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with blood cell and liver function tests as recommended, are necessary.

Uses of Fpgli M 0.5 Tablet PR

Managing type 2 diabetes

Major Benefits of Fpgli M 0.5 Tablet PR:

Follow your doctor's instructions or refer to the product label for usage guidance. Administer Fpgli M 0.5 Tablet PR with food.

Common Side effects of Fpgli M 0.5 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Fpgli M 0.5 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Administer Fpgli M 0.5 Tablet PR with food.

How Fpgli M 0.5 Tablet PR works:

Fpgli M 0.5 Tablet PR combines glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to produce more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Fpgli M 0.5 Tablet PR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The medication Fpgli M 0.5 Tablet PR might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Use of Fpgli M 0.5 Tablet PR is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates the medication may harm the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Fpgli M 0.5 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Fpgli M 0.5 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate hepatic dysfunction, initiation at a low dose is typical; however, it's contraindicated in those with severe liver disease.

What if you forget to take Fpgli M 0.5 Tablet PR :

For Fpgli M 0.5 Tablet PR, take any missed dose promptly. If your next dose is imminent, however, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Fpgli M 0.5 Tablet PR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Fpgli M 0.5 Tablet PR

Store this medication in its original, tightly sealed container or packaging, following the storage guidelines provided on the label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Indeed, Fpgli M 0.5 Tablet PR administration can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this infrequent adverse reaction to metformin poses a significant risk to individuals with pre-existing kidney impairment, the elderly, or those consuming substantial alcohol. Manifestations of lactic acidosis might encompass muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Fpgli M 0.5 Tablet PR use and seek immediate medical attention.
The medication Fpgli M 0.5 Tablet PR contains glimepiride and metformin, acting together to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances blood sugar control when combined with a balanced diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Taking Fpgli M 0.5 Tablet PR may cause common side effects such as low blood sugar, taste changes, queasiness, abdominal discomfort, loose stools, and headaches. Rarely, but seriously, lactic acidosis can occur. Prolonged use might result in a Vitamin B12 deficiency.
Prolonged use of Fpgli M 0.5 Tablet PR can indeed lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as peripheral neuropathy (tingling and numbness in extremities), muscle weakness, urinary dysfunction, cognitive changes, and impaired gait (ataxia). Preventive strategies proposed by some researchers include annual supplemental Vitamin B12 intake.
Indeed, Fpgli M 0.5 Tablet PR can induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Fpgli M 0.5 Tablet PR and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Fpgli M 0.5 Tablet PR
70
MRP 86
18% off